Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
31.98
+0.03 (0.09%)
Nov 21, 2024, 4:00 PM EST - Market closed
Edgewise Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 44.81 | 86.1 | 21.99 | 15.57 | 104.92 | 23.65 |
Short-Term Investments | 447.73 | 232.3 | 329.95 | 265.22 | 24.18 | - |
Cash & Short-Term Investments | 492.54 | 318.39 | 351.95 | 280.79 | 129.09 | 23.65 |
Cash Growth | 70.02% | -9.53% | 25.34% | 117.51% | 445.78% | - |
Prepaid Expenses | 6.9 | 8.6 | 5.05 | 2.98 | 0.55 | 0.39 |
Total Current Assets | 499.44 | 327 | 357 | 283.77 | 129.65 | 24.04 |
Property, Plant & Equipment | 11.58 | 12.69 | 9.85 | 0.91 | 0.52 | 0.5 |
Long-Term Deferred Charges | 0.26 | 0.3 | 0.25 | - | 0.7 | - |
Other Long-Term Assets | - | 0.05 | - | 0.55 | 0.28 | - |
Total Assets | 511.28 | 340.04 | 367.1 | 285.23 | 131.14 | 24.54 |
Accounts Payable | 5.65 | 4.03 | 6.11 | 3.84 | 1.58 | 0.67 |
Accrued Expenses | 12.32 | 11.77 | 9.87 | 6.68 | 2.31 | 0.47 |
Current Portion of Leases | 0.99 | 0.98 | 0.61 | - | - | - |
Other Current Liabilities | - | - | - | - | 0.45 | - |
Total Current Liabilities | 18.96 | 16.77 | 16.59 | 10.52 | 4.34 | 1.13 |
Long-Term Leases | 3.45 | 4.43 | 3.8 | - | - | - |
Other Long-Term Liabilities | - | - | - | 0.33 | - | - |
Total Liabilities | 22.41 | 21.21 | 20.39 | 10.85 | 4.34 | 1.13 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | - | - |
Additional Paid-In Capital | 826.73 | 563.49 | 492.67 | 351.85 | 0.73 | 0.17 |
Retained Earnings | -338.91 | -244.76 | -144.6 | -76.96 | -34.15 | -17.02 |
Comprehensive Income & Other | 1.05 | 0.1 | -1.36 | -0.51 | - | - |
Total Common Equity | 488.88 | 318.83 | 346.72 | 274.38 | -33.42 | -16.85 |
Shareholders' Equity | 488.88 | 318.83 | 346.72 | 274.38 | 126.79 | 23.41 |
Total Liabilities & Equity | 511.28 | 340.04 | 367.1 | 285.23 | 131.14 | 24.54 |
Total Debt | 4.44 | 5.41 | 4.41 | - | - | - |
Net Cash (Debt) | 488.1 | 312.98 | 347.54 | 280.79 | 129.09 | 23.65 |
Net Cash Growth | 71.76% | -9.94% | 23.77% | 117.51% | 445.78% | - |
Net Cash Per Share | 5.75 | 4.91 | 6.48 | 7.48 | 174.69 | 62.61 |
Filing Date Shares Outstanding | 94.69 | 93.11 | 63.26 | 49.51 | 1.01 | 0.42 |
Total Common Shares Outstanding | 94.41 | 70.45 | 63.26 | 49.5 | 1.01 | 0.42 |
Working Capital | 480.48 | 310.23 | 340.41 | 273.25 | 125.3 | 22.91 |
Book Value Per Share | 5.18 | 4.53 | 5.48 | 5.54 | -33.11 | -40.22 |
Tangible Book Value | 488.88 | 318.83 | 346.72 | 274.38 | -33.42 | -16.85 |
Tangible Book Value Per Share | 5.18 | 4.53 | 5.48 | 5.54 | -33.11 | -40.22 |
Machinery | 4.53 | 4.25 | 2.26 | 1.61 | - | - |
Construction In Progress | - | 0.08 | 7.34 | - | - | - |
Leasehold Improvements | 9.55 | 8.73 | - | - | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.